How Is The Transcatheter Aortic Valve Replacement Market Expected To Grow At 14.2% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Transcatheter Aortic Valve Replacement Market In The Coming Years?
There has been exponential growth in the Transcatheter Aortic Valve Replacement market size in the past few years. The market is set to expand from $5.19 billion in 2024 to $5.87 billion in 2025, registering a Compound Annual Growth Rate (CAGR) of 13.2%. The historical growth trend can be credited to the escalating occurrence of aortic regurgitation, the increase in cardiovascular diseases, a growing inclination towards minimally invasive treatments from patients, the worldwide growth of TAVR procedures and beneficial reimbursement policies.
Expectations are high for the transcatheter aortic valve replacement market, with substantial growth forecasted in the coming years. The market is projected to increase to $9.99 billion by 2029, flourishing at a compound annual growth rate (CAGR) of 14.2%. Factors such as the rising occurrence of aortic stenosis, the growing preference for minimally invasive treatments, expanding uses for TAVR procedures, beneficial reimbursement policies, and heightened awareness of TAVR as a potential treatment pathway, are contributing to this projected growth. Key trends propelling this advancement over the forecast period include the continual development of device technology, an increase in cardiovascular disease cases, worldwide adoption of TAVR procedures, an aging population, and increased healthcare spending.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp
What Drivers Are Accelerating Expansion Of The Transcatheter Aortic Valve Replacement Market?
The rise in the incidence of aortic stenosis is a key contributor to the growing trend in the transcatheter aortic valve replacement market. Aortic stenosis, which is the narrowing of the heart’s aortic valve, can be effectively addressed by transcatheter aortic valve replacement (TAVR). TAVR, a less invasive procedure compared to surgical aortic valve replacement (SAVR), aids in normalizing blood flow and diminishing the symptoms of aortic valve stenosis. For example, data released by the American Heart Association in May 2024 revealed that over 12% of seniors in America suffer from aortic stenosis, a condition commonly seen in those over 65 years of age. If it’s not treated, this condition can lead to heart failure and ultimately, death. Additionally, a report by the National Institute for Health and Care Excellence (NICE) in March 2023 revealed that almost 1.5%, near 300,000, inhabitants over 55 in the UK have severe aortic stenosis, with approximately 200,000 exhibiting symptoms and needing treatment. This resulted in over 380,000 people on cardiac waiting lists by March 2023. As a result, the escalating prevalence of aortic stenosis is propelling the transcatheter aortic valve replacement market.
How Is The Global Transcatheter Aortic Valve Replacement Market Broken Down By Segment?
The transcatheter aortic valve replacementmarket covered in this report is segmented –
1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems
Which Trends Are Likely To Redefine Growth Paths In The Transcatheter Aortic Valve Replacement Market?
Product innovation is emerging as a pivotal factor in the growth of the Transcatheter Aortic Valve Replacement (TAVR) market. Businesses within this sector are channeling efforts into the creation of technologically advanced and innovative solutions with the intention to amplify their market standing. For example, Edwards Lifesciences, a medical technology firm based in the U.S. initiated the distribution of its Sapien 3 Ultra Resilia valve in Europe in May 2024. This marked a unique addition to the Transcatheter Aortic Valve Replacement (TAVR) systems, equipped with the company’s patented Resilia tissue technology. Designed to improve the lifespan of the valve, this cutting-edge technology employs bovine pericardial tissue which has undergone treatment with anti-calcification procedures. Integration of this calcium resisting technology in the Resilia framework functions to lessen structural deterioration of the valve, considered a primary reason for reintervention post valve replacement.
Which Firms Are Making The Biggest Impact In The Transcatheter Aortic Valve Replacement Market?
Major companies operating in the transcatheter aortic valve replacement market include Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Transcatheter Aortic Valve Replacement Market?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12031&type=smp
Browse Through More Reports Similar to the Global Transcatheter Aortic Valve Replacement Market 2025, By The Business Research Company
Motor Vehicle And Parts Dealers Global Market Report 2025
Automobiles And Heavy Equipment Global Market Report 2025
Electric Motor And Generator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
